Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma

Cancer Letters

Volumn 177, Issue 1, 2002, Pages 13-19

  Dong, Youyi ^a   Sui, Li ^a   Watanabe, Yasuo ^a   Sugimoto, Katsuyoshi ^a   Tokuda, Masaaki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cyclin B1; Larynx; Squamous cell carcinoma

Indexed keywords

CYCLIN B1;

ADULT; ADVANCED CANCER; AGED; ANALYTIC METHOD; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CYCLIN B; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL RATE;

EID: 0037040441     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00770-4     Document Type: Article

References (25)

1. The National Cancer Data Base report on cancer of the head and neck
2. Pathologic and cytometric indicators of biologic behaviour in laryngeal cancer
3. G1 phase progression: Cycling on cue
4. Cyclins, CDKs and cancer
5. Cell cycle. Dams and sluices
6. The role of p34 kinases in the G1 to S-phase transition
7. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
8. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia
9. Cyclins and cancer
10. Redundant cyclin overexpression and gene amplification in breast cancer cells
11. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor
12. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: A comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2
13. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses
14. Overexpression of cyclin B1 in human colorectal cancers
15. Expression of cell cycle-regulated proteins in prostate cancer
16. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma
17. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
18. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication
19. Prognostic factors in gastric cancer
20. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer
21. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines
22. Intracellular localization of cyclin B1 during the cell cycle in glioma cells
23. p53 regulates a G2 checkpoint through cyclin B1
24. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest
25. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma